TP53 and neoplasm: In addition, tumors from CK2α/α’-RNAi-treated mice show reduced staining of pro-proliferative proteins (e.g., Cyclin D1) and increased levels of tumor suppressors (e.g., P53) compared to tumors from control mice [37].